MedTrace Logo

Acid Suppressing Drug Seizure Epidemiology Study

NCT01744301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8605

Last updated 2016-09-09

No results posted yet for this study

Summary

The purpose of this study is

1. to estimate the incidence of seizure in the general population and stratified by epilepsy status
2. To estimate the relative risk of seizure associated with use of proton pump inhibitors and histamine 2 receptor antagonist and stratified by epilepsy status

Conditions

  • Seizure

Interventions

DRUG

Risk of seizure

Patients newly prescribed PPI and H2RA, respectively

Sponsors & Collaborators

Principal Investigators

  • Luis a Garcia Rodriguez, MD · CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01744301 on ClinicalTrials.gov